Related Experiment Videos
Hydroxyurea-induced leg ulcers: is macroerythrocytosis a pathogenic factor?
A Vélez1, J M García-Aranda, J C Moreno
1Section of Dermatology, Hospital Universitario Reina Sofía, Córdoba, Spain.
Summary
Hydroxyurea, a cancer drug, can cause leg ulcers. Researchers suggest macroerythrocytosis, a side effect of hydroxyurea treatment, may be the cause of these ulcers.
Area of Science:
- Oncology
- Hematology
- Dermatology
Background:
- Hydroxyurea is a vital chemotherapy agent inhibiting DNA synthesis.
- It is a primary treatment for chronic myelogenous leukemia and essential thrombocythemia.
- Leg ulcers are a known complication in 8.5% of patients on continuous hydroxyurea therapy.
Observation:
- Two new cases of hydroxyurea-induced leg ulcers are presented.
- Macroerythrocytosis, characterized by enlarged red blood cells, is observed in nearly all patients taking hydroxyurea.
Findings:
- The study proposes macroerythrocytosis as a potential pathogenic factor for hydroxyurea-related leg ulcers.
- Macroerythrocytosis is viewed as an acquired blood dyscrasia.
Implications:
- This finding may explain the mechanism behind hydroxyurea-induced leg ulcers.
- Understanding this link could lead to preventative strategies for patients.
- Comparing acquired dyscrasias to hereditary ones like sickle cell anemia offers insights into ulcer formation.